NUTRITION SUPPORT AFFECTS THE DISTRIBUTION AND ORGAN UPTAKE OF CACHECTIN TUMOR-NECROSIS-FACTOR IN RATS

被引:14
作者
KEITH, ME
NORWICH, KH
JEEJEEBHOY, KN
机构
[1] UNIV TORONTO,DEPT NUTR SCI,TORONTO,ON M5S 1A8,CANADA
[2] UNIV TORONTO,DEPT PHYSIOL,TORONTO,ON M5S 1A8,CANADA
[3] UNIV TORONTO,INST BIOMED ENGN,TORONTO,ON M5S 1A8,CANADA
关键词
D O I
10.1177/0148607195019005341
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: We have previously observed a potentiation of the metabolic response to cachectin/tumor necrosis factor (TNF) by total parenteral nutrition (TPN) but not in anorexic orally fed animals. We hypothesized that nutritional status might affect TNF clearance kinetics. Methods: We compared the clearance of a bolus of labeled TNF in TPN-fed animals given sufficient nutrients to grow called weight-gaining rats (WGR) with those given 50% of the WGR called weight-losing rats (WLR) and with orally fed rats (OFR). Data were analyzed using a two-compartment open system model and by linear systems analysis. Result: The data from both types of analysis indicated that although metabolic clearance was similar, WGR had a slower fractional TNF clearance rate (FCR) as well as a larger volume of distribution than WLR or OFR. Further analysis showed that an increased proportion of the total mass of TNF resided in a plasma-associated compartment in WGR compared with WLR and OFR. In addition, WGR had reduced uptake of labeled TNF by the kidney. Conclusion: The data suggest that nutrition support influences either the distribution of TNF or the FCR, resulting in a greater retention in the plasma-associated compartment with intact absolute removal rates. This study has important implications concerning the type of nutrition support provided to the critically ill patient because our data suggest that clinical states with increased circulating TNF levels may be adversely affected by currently available nutritional practices.
引用
收藏
页码:341 / 350
页数:10
相关论文
共 36 条
[1]  
ADERKA D, 1992, LYMPHOKINE CYTOK RES, V11, P157
[2]   STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS [J].
ADERKA, D ;
ENGELMANN, H ;
MAOR, Y ;
BRAKEBUSCH, C ;
WALLACH, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :323-329
[3]  
ADERKA D, 1991, CANCER RES, V15, P5602
[4]  
AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
[5]  
BEMELMANS MHA, 1993, J IMMUNOL, V150, P2007
[6]  
BEMELMANS MHA, 1993, J IMMUNOL, V151, P5554
[7]   PLASMA TUMOR-NECROSIS-FACTOR SOLUBLE RECEPTORS IN CHRONIC-RENAL-FAILURE [J].
BROCKHAUS, M ;
BARKHAYIM, Y ;
GURWICZ, S ;
FRENSDORFF, A ;
HARAN, N .
KIDNEY INTERNATIONAL, 1992, 42 (03) :663-667
[8]  
ENGELMANN H, 1989, J BIOL CHEM, V264, P11974
[9]  
FERRAIOLO BL, 1989, DRUG METAB DISPOS, V17, P369
[10]  
FONG Y, 1989, ANN SURG, V26, P449